Catalyst4, Inc.

Catalyst4, Inc. appears in our data through filings on MapLight Therapeutics, Inc. shares, published by SEC (Form 4). Between 28 October 2025 and 14 August 2026, the trades on record add up to 6 filings.

Purchases make up the whole of the open-market record (5 purchases, €56.8M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 5 purchases and no sales on the market.

In size, the median ticket on the buying side is €1.3M. As a share of market capitalisation, the median purchase stands at 0.25%, based on 5 purchases. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 18 August 2026 with an open-market purchase (€43.4M) in MapLight Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.